Note: Ingredients listed on restricted chemical lists
EC/CAS
253-149-0/36653-82-4
Name of the chemical
1-hexadecanol
Concentration
5 - 10
EC/CAS
204-589-7/122-99-6
Name of the chemical
2-Phenoxyethanol
Concentration
0,1-1
EC/CAS
200-289-5/56-81-5
Name of the chemical
glycerol
Concentration
0,775 – 0,925
EC/CAS
201-766-0/87-69-4
Name of the chemical
L-(+)-tartaric acid
Concentration
<0,1
EC/CAS
208-534-8/532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
<0,1
General Information
Version
1.0
Revision date
2023-03-28
Product name
Stérimar Soothing Nasal Cream (EU GHS (2020/878))
Product Synonyms
Stérimar Crème apaisante contour du nez 1.2
1.2.1 Relevant identified uses
Cream (for skin around the nose) 1.2.2
1.2.2. Uses advised against
For external use only. In case of contact with eyes, rinse immediately with water In case of adverse skin reaction, discontinue use. Do not swallow. Keep out of reach of children
Manufacturer Name
Church & Dwight UK
Emergency telephone
(+44) 08706006266, (+44) 0800 1216080, 1-888-234-1828, (800)255-3924, +1 (813)248-0585
Icons in SDS
Company Information
company name
Church & Dwight UK
e-mail address of the competent person responsible for the Safety Data Sheet
consumer.relationsUK@churchdwight.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Hazard statements
see section 16 : H319 - Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Precautionary statements
P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention.
Other hazards which do not result in classification
Exposure may aggravate pre-existing eye, skin, or respiratory conditions. This substance/mixture does not meet the PBT/vPvB criteria of REACH regulation, annex XIII The substance/mixture does not contain substance(s) equal to or greater than 0.1% by weight that are present in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605